ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 133

An Interdisciplinary Team Approach to Implementation of a Social Determinants of Health Screener for Pediatric Rheumatology Patients

Sarah Campbell1, Rosemary Peterson2, Sarah Barrientos3, Elinore Benett3 and Cori Christenholz3, 1University of Texas at Austin Dell Medical School, Austin, TX, 2Dell Medical School at UT Austin, Austin, TX, 3Dell Children's Medical Center Department of Rheumatology, Austin, TX

Meeting: 2023 Pediatric Rheumatology Symposium

Keywords: Access to care, Health Assessment Questionnaire (HAQ), socioeconomic factors

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Friday, March 31, 2023

Title: Posters: Quality, Health Services, and Education II

Session Type: Poster Session B

Session Time: 5:00PM-6:00PM

Background/Purpose: Adolescents with chronic disease often struggle with the transition from pediatric to adult healthcare leading to poor follow-up and negative health outcomes. Social determinants of health (SDoH) such as income, food insecurity, and immigration status likely have a significant impact on transition success. This study aims to successfully implement a standardized approach to SDoH screening and proactive social work involvement for pediatric rheumatology patients.

Methods: An interprofessional team was created to proactively identify psychosocial barriers to successful transition from pediatric to adult care in an outpatient pediatric rheumatology clinic. Eligibility criteria included established patients, age 14 or older, with chronic rheumatic disease, present with a legal guardian. The SDoH screener, adapted from the Health Leads Screening Toolkit, was given to eligible patients every 6 months (Figure 1). The primary outcome was the percent of eligible patients who completed the SDoH screener, and the secondary outcome was the percent of positive screens who met in-person or via phone with the clinic’s social worker. A daily secure message was sent to providers and medical assistants to confirm family suitability for receiving the SDoH screener. Upon checking-in, eligible patients’ guardians were given the screener and a cover sheet explaining its purpose. Medical assistants collected the screeners and promptly shared results with the provider and social worker in the original text thread. Families with positive screens, defined as one or more “yes” responses, were asked if they would like to meet with the social worker. The SDoH screener was integrated into the clinic in August 2022. At the end of August, a meeting was held to reeducate staff about the SDoH screening process flow (Plan-Do-Study-Act (PDSA) cycle 1). In October 2022, the workflow was modified to include patients seen in the infusion center (PDSA cycle 2).

Results: Preliminary results were collected August through December, 2022. On average, 71% of eligible patients completed the SDoH screener each month (Figure 2). Of those completed (n = 59), 15% (n = 9) of patients screened positive. 89% of patients with a positive screen directly interfaced with social work at the time of their visit or via phone shortly thereafter. Identified barriers to completion of the SDoH screener include families feeling psychosocially/medically overwhelmed, staff forgetting to disseminate the SDoH, and the morning message not being sent before family arrival (Figure 3).

Conclusion: Implementation of a standardized SDoH screener was successful through interdisciplinary teamwork and communication. This has led to identification of potential barriers to care and proactive integration of social work support for the adolescent rheumatology patients. Next steps include collecting patient-facing feedback regarding SDoH screening acceptability and collection procedures, analysis of the correlation between SDoH screener results and transition outcomes and implementation of further PDSA cycles to address barriers to integration of SDoH screeners into clinic workflow.

Supporting image 1This figure shows the screener used to screen for social determinants of health in the pediatric Rheumatology clinic.

Supporting image 2This figure shows the rate of completion of social determinants of health screeners from August 2022 to December 2022. The initiation of different PDSA cycles are indicated.

Supporting image 3This figure shows the rate of different barriers that prevented the completion of the social determinants of health screener.


Disclosures: S. Campbell: None; R. Peterson: None; S. Barrientos: None; E. Benett: None; C. Christenholz: None.

To cite this abstract in AMA style:

Campbell S, Peterson R, Barrientos S, Benett E, Christenholz C. An Interdisciplinary Team Approach to Implementation of a Social Determinants of Health Screener for Pediatric Rheumatology Patients [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 4). https://acrabstracts.org/abstract/an-interdisciplinary-team-approach-to-implementation-of-a-social-determinants-of-health-screener-for-pediatric-rheumatology-patients/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2023 Pediatric Rheumatology Symposium

ACR Meeting Abstracts - https://acrabstracts.org/abstract/an-interdisciplinary-team-approach-to-implementation-of-a-social-determinants-of-health-screener-for-pediatric-rheumatology-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology